Ameriprise reports 7.1% stake in Personalis
Ameriprise Financial, Inc. filed a Schedule 13G reporting a significant ownership stake in Personalis, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ameriprise Financial, Inc. filed a Schedule 13G reporting a significant ownership stake in Personalis, Inc. common stock. As of 12/31/2025, Ameriprise reports beneficial ownership of 6,287,151 shares, representing 7.1% of Personalis’ outstanding common stock.
Ameriprise reports no sole voting or dispositive power, with all reported voting and dispositive power shared across these holdings. The firm states that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Personalis, and disclaims beneficial ownership of the shares reported.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Ameriprise Financial report in Personalis, Inc. (PSNL)?
Why did Ameriprise file a Schedule 13G for Personalis (PSNL)?
Does Ameriprise Financial seek to influence control of Personalis, Inc.?
Does Ameriprise Financial claim full beneficial ownership of its PSNL position?
Who signed the Ameriprise Schedule 13G regarding Personalis (PSNL)?
AI-generated analysis. How Rhea-AI works. Not financial advice.